A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder

Author: Armstrong Edward P.   Malone Daniel C.   Erder M. Haim  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.24, Iss.4, 2008-04, pp. : 1115-1121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content